Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8869 |
High Similarity |
NPD8434 |
Phase 2 |
0.8333 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.8333 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.8153 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.814 |
Intermediate Similarity |
NPD6765 |
Approved |
0.814 |
Intermediate Similarity |
NPD6764 |
Approved |
0.8133 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7955 |
Intermediate Similarity |
NPD6784 |
Approved |
0.7955 |
Intermediate Similarity |
NPD6785 |
Approved |
0.7927 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7892 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7862 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7829 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7784 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7771 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7758 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7751 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7751 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7725 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7683 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7669 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7661 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7657 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7636 |
Intermediate Similarity |
NPD920 |
Approved |
0.7633 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7625 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7625 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7622 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7602 |
Intermediate Similarity |
NPD919 |
Approved |
0.76 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.759 |
Intermediate Similarity |
NPD8404 |
Phase 2 |
0.7588 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7588 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7574 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7556 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7543 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7529 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7515 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7514 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7514 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7486 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7471 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7453 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7446 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7444 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7444 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7442 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.744 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7427 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7425 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7414 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7412 |
Intermediate Similarity |
NPD37 |
Approved |
0.741 |
Intermediate Similarity |
NPD5401 |
Approved |
0.741 |
Intermediate Similarity |
NPD2534 |
Approved |
0.741 |
Intermediate Similarity |
NPD2532 |
Approved |
0.741 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7407 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7401 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7391 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7386 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7386 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7386 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7384 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7384 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7384 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7378 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7362 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7346 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7337 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7321 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7317 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7305 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7303 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7301 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7301 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7299 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7289 |
Intermediate Similarity |
NPD7236 |
Approved |
0.7283 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7278 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7256 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7246 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7239 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7239 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7233 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7233 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7233 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7232 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7232 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7228 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7216 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7213 |
Intermediate Similarity |
NPD8407 |
Phase 2 |
0.7212 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7207 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.7205 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7198 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7178 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7175 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.7169 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7169 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7169 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7167 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7167 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7161 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7151 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7143 |
Intermediate Similarity |
NPD8368 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7127 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7126 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7126 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7125 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7125 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7111 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7091 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7091 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7089 |
Intermediate Similarity |
NPD5647 |
Approved |
0.7088 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7081 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7079 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7076 |
Intermediate Similarity |
NPD7239 |
Suspended |
0.7069 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7066 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7066 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7062 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7062 |
Intermediate Similarity |
NPD7497 |
Discontinued |
0.7059 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7055 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7049 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7049 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7037 |
Intermediate Similarity |
NPD1240 |
Approved |
0.703 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7025 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7025 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7011 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.6995 |
Remote Similarity |
NPD6777 |
Approved |
0.6995 |
Remote Similarity |
NPD6778 |
Approved |
0.6995 |
Remote Similarity |
NPD6782 |
Approved |
0.6995 |
Remote Similarity |
NPD6779 |
Approved |
0.6995 |
Remote Similarity |
NPD6780 |
Approved |
0.6995 |
Remote Similarity |
NPD6781 |
Approved |
0.6995 |
Remote Similarity |
NPD6776 |
Approved |
0.6994 |
Remote Similarity |
NPD447 |
Suspended |
0.6988 |
Remote Similarity |
NPD6002 |
Phase 3 |
0.6988 |
Remote Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD6005 |
Phase 3 |
0.6988 |
Remote Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD6004 |
Phase 3 |
0.6981 |
Remote Similarity |
NPD2798 |
Approved |
0.6975 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6971 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.697 |
Remote Similarity |
NPD4308 |
Phase 3 |
0.6968 |
Remote Similarity |
NPD8435 |
Approved |
0.6968 |
Remote Similarity |
NPD8361 |
Approved |
0.6968 |
Remote Similarity |
NPD8360 |
Approved |
0.6968 |
Remote Similarity |
NPD17 |
Approved |
0.6957 |
Remote Similarity |
NPD7240 |
Approved |
0.6943 |
Remote Similarity |
NPD3972 |
Approved |
0.6932 |
Remote Similarity |
NPD5616 |
Clinical (unspecified phase) |
0.6923 |
Remote Similarity |
NPD3057 |
Approved |
0.6923 |
Remote Similarity |
NPD7177 |
Discontinued |
0.6923 |
Remote Similarity |
NPD2354 |
Approved |
0.6923 |
Remote Similarity |
NPD3887 |
Approved |
0.6923 |
Remote Similarity |
NPD2163 |
Approved |
0.6919 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6918 |
Remote Similarity |
NPD2797 |
Approved |
0.6914 |
Remote Similarity |
NPD1699 |
Clinical (unspecified phase) |
0.6912 |
Remote Similarity |
NPD4111 |
Phase 1 |
0.6912 |
Remote Similarity |
NPD4665 |
Approved |
0.6909 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6907 |
Remote Similarity |
NPD4107 |
Approved |
0.6906 |
Remote Similarity |
NPD2403 |
Approved |
0.6906 |
Remote Similarity |
NPD4575 |
Clinical (unspecified phase) |
0.6902 |
Remote Similarity |
NPD5953 |
Discontinued |
0.6897 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.689 |
Remote Similarity |
NPD230 |
Phase 1 |
0.689 |
Remote Similarity |
NPD1933 |
Approved |
0.689 |
Remote Similarity |
NPD5735 |
Approved |
0.6889 |
Remote Similarity |
NPD5710 |
Approved |
0.6889 |
Remote Similarity |
NPD5711 |
Approved |
0.6879 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6878 |
Remote Similarity |
NPD4287 |
Approved |
0.686 |
Remote Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.686 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6859 |
Remote Similarity |
NPD1778 |
Approved |
0.6856 |
Remote Similarity |
NPD8285 |
Discontinued |
0.685
|
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |